Publications

726Mo Outcomes by Histology and Prior Therapy with Lenvatinib plus Pembrolizumab Vs Treatment of Physician’s Choice in Patients with Advanced Endometrial Cancer (Study 309/Keynote-775)

AuthID
P-00V-T8J

Author(s)

Colombo, N

Lorusso, D

Herráez, AC

Santin, A

Colomba, E

Miller, D

Fujiwara, K

Pignata, S

Floquet, A

Monk, B

Banerjee, S

Penson, R

Kristeleit, R

Fabbro, M

Orlando, M

Mackay, H

Jensen, E

Dutta, L

Orlowski, R

Makker, V

Document Type

Article

Year published

2021

Published

in Annals of Oncology, ISSN: 0923-7534

Volume: 32, Pages: S729-S730

Indexing

Crossref^®17

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.annonc.2021.08.1169

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

726Mo Outcomes by Histology and Prior Therapy with Lenvatinib plus Pembrolizumab Vs Treatment of Physician’s Choice in Patients with Advanced Endometrial Cancer (Study 309/Keynote-775)

Useful Links

Get Help

Federated Authentication (Click on the image)

726Mo Outcomes by Histology and Prior Therapy with Lenvatinib plus Pembrolizumab Vs Treatment of Physician’s Choice in Patients with Advanced Endometrial Cancer (Study 309/Keynote-775)

Useful Links

Get Help